Literature DB >> 15700047

Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function.

F Hu, X Wang, T W W Pace, H Wu, A H Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15700047      PMCID： PMC1237050          DOI： 10.1038/sj.mp.4001644

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  11 in total

Review 1.  Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.

Authors:  C M Pariante; A H Miller
Journal:  Biol Psychiatry       Date:  2001-03-01       Impact factor: 13.382

2.  Inflammatory blockade restores adult hippocampal neurogenesis.

Authors:  Michelle L Monje; Hiroki Toda; Theo D Palmer
Journal:  Science       Date:  2003-11-13       Impact factor: 47.728

3.  The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells.

Authors:  C M Pariante; B D Pearce; T L Pisell; C Su; A H Miller
Journal:  J Endocrinol       Date:  2001-05       Impact factor: 4.286

4.  Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase.

Authors:  I Rogatsky; S K Logan; M J Garabedian
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

5.  Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine.

Authors:  C M Pariante; B D Pearce; T L Pisell; M J Owens; A H Miller
Journal:  Mol Pharmacol       Date:  1997-10       Impact factor: 4.436

Review 6.  The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection.

Authors:  J Licinio; M L Wong
Journal:  Mol Psychiatry       Date:  1999-07       Impact factor: 15.992

7.  Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction.

Authors:  Silvia Rossi Paccani; Marianna Boncristiano; Cristina Ulivieri; Mario Milco D'Elios; Gianfranco Del Prete; Cosima T Baldari
Journal:  J Biol Chem       Date:  2001-11-07       Impact factor: 5.157

8.  A role for COX-2 and p38 mitogen activated protein kinase in long-term depression in the rat dentate gyrus in vitro.

Authors:  H J Murray; J J O'Connor
Journal:  Neuropharmacology       Date:  2003-03       Impact factor: 5.250

Review 9.  When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders.

Authors:  Charles L Raison; Andrew H Miller
Journal:  Am J Psychiatry       Date:  2003-09       Impact factor: 18.112

10.  Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism.

Authors:  L I McKay; J A Cidlowski
Journal:  Mol Endocrinol       Date:  1998-01
View more
  19 in total

1.  Psychosis as an adverse effect of monoclonal antibody immunotherapy.

Authors:  Norah Essali; David R Goldsmith; Laura Carbone; Brian J Miller
Journal:  Brain Behav Immun       Date:  2019-06-03       Impact factor: 7.217

2.  Immune System and Schizophrenia.

Authors:  Norbert Müller; Markus J Schwarz
Journal:  Curr Immunol Rev       Date:  2010-08

3.  Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia.

Authors:  Sisi Liu; Emmanouil Saloustros; Annabel Berthon; Matthew F Starost; Isabelle Sahut-Barnola; Paraskevi Salpea; Eva Szarek; Fabio R Faucz; Antoine Martinez; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2015-10-05       Impact factor: 5.678

4.  Different susceptibility of prefrontal cortex and hippocampus to oxidative stress following chronic social isolation stress.

Authors:  Jelena Zlatković; Nevena Todorović; Maja Bošković; Snežana B Pajović; Miroslav Demajo; Dragana Filipović
Journal:  Mol Cell Biochem       Date:  2014-03-27       Impact factor: 3.396

Review 5.  Inflammatory biomarkers and depression.

Authors:  Norbert Müller; Aye-Mu Myint; Markus J Schwarz
Journal:  Neurotox Res       Date:  2010-07-24       Impact factor: 3.911

Review 6.  Epilepsy Associated Depression: An Update on Current Scenario, Suggested Mechanisms, and Opportunities.

Authors:  Tanveer Singh; Rajesh Kumar Goel
Journal:  Neurochem Res       Date:  2021-03-04       Impact factor: 3.996

Review 7.  Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression.

Authors:  Thaddeus W W Pace; Fang Hu; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2006-10-27       Impact factor: 7.217

Review 8.  Cytokines and glucocorticoid receptor signaling. Relevance to major depression.

Authors:  Thaddeus W W Pace; Andrew H Miller
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 9.  [Immunological aspects of depressive disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

Review 10.  A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders.

Authors:  Norbert Müller; Markus J Schwarz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.